ORIGIN In The News

More than 7,300 delegates at the American Diabetes Association's 72nd Scientific Sessions, were on hand to hear the first public presentation of the ORIGIN Trial results, as presented by the ORIGIN Trial Operations Committee on June 11, 2012 in Philadelphia.

Top ORIGIN Trial News:

Sanofi’s insulin glargine delays progression from pre-diabetes to T2DM
Posted June 15, 2012 by News Medical

ADA: Omega-3 fatty acids don't cut CV death
Posted June 15, 2012 by The Clinical Advisor

Insulin glargine gets resounding safety vote
Posted June 13, 2012 by Canadian Medical Association

Omega-3 supplementation fails to prevent CV events in diabetes
Posted June 13, 2012 by Canadian Medical Association

Omega-3 fish oil supplements questioned
Posted June 13, 2012 by CBC News

Long-term insulin use does not increase risk of heart disease in people with diabetes
Posted June 13, 2012 by News Medical

Leading Insulin Doesn't Heighten Cancer Risk, Studies Find
Posted June 12, 2012 by The Wall Street Journal

ADA: No Cancer Risk with Lantus
Posted June 12, 2012 by MedPage Today

Fish oil components may not benefit everyone's heart
Posted June 12, 2012 by Science News

Heart, cancer risk no higher with long-term insulin use
Posted June 12, 2012 by CBC News

ADA cancer-risk data clears Sanofi's Lantus
Posted June 12, 2012 by FiercePharma

Sanofi reports results of ORIGIN trail
Posted June 12, 2012 by MENAFN

McMaster study debunks belief insulin puts people with diabetes at risk of heart disease
Posted June 12, 2012 by McMaster Daily News

The ORIGIN Trial: 8 questions, 8 answers
Posted June 11, 2012 by Diabetes-symposium.org

Sanofi’s Lantus Had No Increased Cancer Risk in Studies
Posted June 11, 2012 by Bloomberg

Fish Oil Or Snake Oil? Study Questions Omega-3 Benefits
Posted June 11, 2012 by Forbes

Three studies back Sanofi's Lantus safety
Posted June 11, 2012 by Reuters

Sanofi Announces Results Of Origin Trial
Posted June 11, 2012 by RTTNews

Sanofi's Lantus Doesn't Reduce Heart-Attack Risk in Diabetes Study
Posted June 11, 2012 by Fox Business

Fish Oil Won't Save Diabetics' Hearts, Research Suggests
Posted June 11, 2012 by US News

ORIGIN: Insulin glargine and n-3 fatty acids do not reduce CVD events in diabetics
Posted June 11, 2012 by theheart.org

ADA: Omega-3 Fatty Acids Don’t Cut Cardiovascular Death
Posted June 11, 2012 by DoctorsLounge